If dragons are one of your favorite things in Elden Ring: Shadow of the Erdtree, you’ll be happy to know that your character can become one if you get the Dragon Form. And not only one type of dragon, ...

Members of the United Nurses Associations of California/Union of Health Care Professionals plan to begin a three-day strike Nov. 26 at San Diego-based Sharp HealthCare. The union represents one unit ...

“Interviews are NOT real anymore.” So reads the opening caption of a TikTok posted in September, punctuated by the skull-and-crossbones emoji. In the video, a young woman interviews for a job on a ...

Sharp plans to decide on transferring large-size LCD panel technology to India by the end of 2025, CEO Masahiro Okitsu said, signaling potential expansion of the country's display manufacturing ...

Do you find yourself being harshly self-critical after you’ve made a mistake or failed to meet a personal goal? Familiar self-statements might be: “I can’t seem to do anything right!” or “I’m just not ...

Electricity bills are climbing nationwide, rising faster than inflation in many places. The explosive growth of AI and the massive data centers behind it are driving demand and straining the grid. To ...

When it comes to your current wellness routine, taking care of your brain probably isn’t as high up on the list as, say, your skin or core strength. But it should be. The good news is that the habits ...

A screengrab of Return to the Land founder Eric Orwoll, taken from a video he posted to X. Credit: X screengrab Dozens of young people from across the country have settled onto 157 acres of rolling ...

John Bonelli is a news writer for Game Rant who's been writing about video games since 2017. He fell in love with gaming upon playing Fallout 3 for the first time in 2013; it's still his favorite ...

SAN FRANCISCO--(BUSINESS WIRE)--Develop Health, an EHR-integrated benefits‑verification and prior‑authorization platform, today announced a $14.3 million Series A led by Wing Venture Capital, with ...

In an Aug. 7 earnings call, Eli Lilly CEO David Ricks told investors that the company plans to submit the drug, orforglipron, to the FDA for approval by the end of the year. Dan Skovronsky, chief ...